Abstract
Purpose
There is no sufficient data about the clinical course and outcome in thyroid cancer patients who become pregnant after diagnosis of distant metastasis (DM). The current study was conducted to collect information regarding the clinical and reproductive characteristics, and outcomes in thyroid cancer patients who became pregnant after being diagnosed with DM.
Methods
Records of 125 differentiated thyroid cancer (DTC) patients with age ≤45 years at DM diagnosis who had visited Ito Hospital from January 2005 to June 2021 were retrospectively reviewed. Among those 125 patients, 28 who became pregnant after DM diagnosis were classified as pregnancy group, and the remained 97 patients were classified as comparator group.
Results
In pregnancy group, the median age at malignancy diagnosis, DM diagnosis, and first pregnancy after DM diagnosis was 25 years (range, 4–41 years), 27 years (range, 11–41 years), and 32 years (range, 25–45 years), respectively. Fifty-five pregnancies and 40 live births were reported. Other pregnancy outcomes were miscarriage (n = 14) and induced abortion (n = 1). The 10-year progression-free survival (PFS) rates of pregnant and comparator group were 92.1% and 74.4%, respectively (p = 0.018). The multivariate analysis showed that multiple 131I treatment was independent negative prognostic factor for PFS (p = 0.046).
Conclusions
DTC patients with age ≤45 years at DM diagnosis had good survival even though they became pregnant. Our results add to the information required for counseling thyroid cancer patients who have concerns about their fertility in the future.
Similar content being viewed by others
References
E. Macerola, A.M. Poma, P. Vignali, A. Basolo, C. Ugolini, L. Torregrossa, F. Santini, F. Basolo, Molecular genetics of follicular-derived thyroid cancer. Cancers (Basel) 13, 1139 (2021)
H. Yamazaki, H. Iwasaki, H. Takasaki, N. Suganuma, R. Sakai, K. Masudo, H. Nakayama, Y. Rino, M. Masuda, Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer. Medicine (Baltimore) 98, e14774 (2019)
K. Matsuzu, K. Sugino, K. Masudo, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, T. Uruno, A. Suzuki, S. Magoshi, J. Akaishi, C. Masaki, M. Kawano, N. Suganuma, Y. Rino, M. Masuda, K. Kameyama, H. Takami, K. Ito, Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J. Surg. 38, 68–79 (2014)
M.E. Cabanillas, M.A. Habra, Lenvatinib: role in thyroid cancer and other solid tumors. Cancer Treat Rev. 42, 47–55 (2016)
C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892–2899 (2006)
A.R. Shaha, J.C. Migliacci, I.J. Nixon, L.Y. Wang, R.J. Wong, L.G.T. Morris, S.G. Patel, J.P. Shah, R.M. Tuttle, I. Ganly, Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer. Surgery 165, 6–11 (2019)
I.J. Nixon, L.Y. Wang, J.C. Migliacci, A. Eskander, M.J. Campbell, A. Aniss, L. Morris, F. Vaisman, R. Corbo, D. Momesso, M. Vaisman, A. Carvalho, D. Learoyd, W.D. Leslie, R.W. Nason, D. Kuk, V. Wreesmann, L. Morris, F.L. Palmer, I. Ganly, S.G. Patel, B. Singh, R.M. Tuttle, A.R. Shaha, M. Gönen, K.A. Pathak, W.T. Shen, M. Sywak, L. Kowalski, J. Freeman, N. Perrier, J.P. Shah, An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer. Thyroid 26, 373–380 (2016)
K. Sugino, M. Nagahama, W. Kitagawa, K. Ohkuwa, T. Uruno, K. Matsuzu, A. Suzuki, C. Tomoda, K.Y. Hames, J. Akaishi, C. Masaki, K. Ito, Distant metastasis in pediatric and adolescent differentiated thyroid cancer: clinical outcomes and risk factor analyses. J. Clin. Endocrinol. Metab. 105(11), dgaa545 (2020)
C.M. Cottreau, I. Dashevsky, S.E. Andrade, D.K. Li, L. Nekhlyudov, M.A. Raebel, D.P. Ritzwoller, A.H. Partridge, P.A. Pawloski, S. Toh, Pregnancy-associated cancer: a U.S. population-based study. J. Womens Health 28, 250–257 (2019)
M. Derwahl, D. Nicula, Estrogen and its role in thyroid cancer. Endocr. Relat. Cancer 21, T273–T283 (2014)
Y. Ito, A. Miyauchi, T. Kudo, H. Ota, K. Yoshioka, H. Oda, H. Sasai, A. Nakayama, T. Yabuta, H. Masuoka, M. Fukushima, T. Higashiyama, M. Kihara, K. Kobayashi, A. Miya, Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. Thyroid 26, 156–160 (2016)
A.C. Chen, M.J. Livhits, L. Du, J.X. Wu, E.J. Kuo, M.W. Yeh, A.M. Leung, Recent pregnancy is not associated with high-risk pathological features of well-differentiated thyroid cancer. Thyroid 28, 68–71 (2018)
C. Xi, Q. Zhang, H.J. Song, C.T. Shen, G.Q. Zhang, J.W. Sun, Z.L. Qiu, Q.Y. Luo, Pregnancy does not affect the prognoses of differentiated thyroid cancer patients with lung metastases. J. Clin. Endocrinol. Metab. 106, e3185–e3197 (2021)
S. Takahashi, A. Horie, S. Yamamura, A. Kawamura, A. Yamaguchi, M. Sunada, H. Tani, H. Mogami, J. Hamanishi, E. Kondoh, M. Mandai, Oncofertility care in young women and the outcomes of pregnancy over the last 5 years. Future Sci. OA 7, FSO680 (2021)
E. Sullivan, Y. Wang, M. Chapman, G. Chambers, Success rates and cost of a live birth following fresh assisted reproduction treatment in women aged 45 years and older, Australia 2002-2004. Hum. Reprod. 23, 1639–1643 (2008)
Y. Kanda, Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48, 452–458 (2013)
Y. Ito, N. Onoda, T. Okamoto, The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr. J. 67, 669–717 (2020)
H.J. Song, Z.L. Qiu, C.T. Shen, W.J. Wei, Q.Y. Luo, Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur. J. Endocrinol. 173, 399–408 (2015)
A.M. Sawka, D.C. Lakra, J. Lea, B. Alshehri, R.W. Tsang, J.D. Brierley, S. Straus, L. Thabane, A. Gafni, S. Ezzat, S.R. George, D.P. Goldstein, A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin. Endocrinol. 69, 479–490 (2008)
M. Nies, A.E.P. Cantineau, E.G.J.M. Arts, M.H. van den Berg, F.E. van Leeuwen, A.C. Muller Kobold, M.S. Klein Hesselink, J.G.M. Burgerhof, A.H. Brouwers, E.W.C.M. van Dam, B. Havekes, M.M. van den Heuvel-Eibrink, E.P.M. Corssmit, L.C.M. Kremer, R.T. Netea-Maier, H.J.H. van der Pal, R.P. Peeters, J.T.M. Plukker, C.M. Ronckers, H.M. van Santen, A.N.A. van der Horst-Schrivers, W.J.E. Tissing, G. Bocca, E. van Dulmen-den Broeder, T.P. Links, Long-term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma. Thyroid 30, 1169–1176 (2020)
K.Y. Ko, R.F. Yen, C.L. Lin, M.F. Cheng, W.S. Huang, C.H. Kao, Pregnancy outcome after I-131 therapy for patients with thyroid cancer: a nationwide population-based cohort study. Medicine (Baltimore) 95, e2685 (2016)
J.X. Wu, S. Young, K. Ro, N. Li, A.M. Leung, H.K. Chiu, A. Harari, M.W. Yeh, Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer. Thyroid 25, 133–138 (2015)
M. Sugiura-Ogasawara, Y. Ozaki, T. Kitaori, N. Suzumori, S. Obayashi, S. Suzuki, Live birth rate according to maternal age and previous number of recurrent miscarriages. Am. J. Reprod. Immunol. 62, 314–319 (2009)
K. Kawase, K. Nomura, S. Nomura, S. Akashi-Tanaka, T. Ogawa, I. Shibasaki, M. Shimada, T. Taguchi, E. Takeshita, Y. Tomizawa, K. Hanazaki, T. Hanashi, H. Yamauchi, H. Yamashita, S. Nakamura, How pregnancy and childbirth affect the working conditions and careers of women surgeons in Japan: findings of a nationwide survey conducted by the Japan Surgical Society. Surg. Today 51, 309–321 (2021)
I. Messuti, S. Corvisieri, F. Bardesono, I. Rapa, J. Giorcelli, R. Pellerito, M. Volante, F. Orlandi, Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur. J. Endocrinol. 170, 659–666 (2014)
M. Harada, Y. Osuga, Fertility preservation for female cancer patients. Int. J. Clin. Oncol. 24, 28–33 (2019)
Acknowledgements
We thank Enago (https://www.enago.jp/) for editing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Ito Hospital (approval number 336) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yamazaki, H., Sugino, K., Noh, J.Y. et al. Clinical course and outcome of differentiated thyroid cancer patients with pregnancy after diagnosis of distant metastasis. Endocrine 76, 78–84 (2022). https://doi.org/10.1007/s12020-021-02969-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02969-7